Why Actinium Pharmaceuticals’ Stock Is Trading Higher Today
Actinium Pharmaceuticals (AMEX:ATNM) shares are trading higher after the company announced it completed enrollment in the pivotal Phase 3 SIERRA trial of iomab-B.
38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Actinium Completes Enrollment In The Pivotal Phase 3 SIERRA Trial Of Iomab-B
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium" or the "Company") today announced that it has completed enrollment of the pivotal Phase 3 SIERRA trial for Iomab-B, an Antibody
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 83 companies set new 52-week lows.
Actinium’s Targeted Radiotherapy Achieves 100% Bone Marrow Transplant Engraftment
Actinium Pharmaceuticals Inc (NYSE:ATNM) highlighted data from its pivotal Phase 3 SIERRA trial evaluating Iomab-B in patients with relapsed or refractory…
Actinium Pharmaceuticals Says Safety Data Highlighting Low Rates Of Adverse Events And Non-Relapse Transplant Related Mortality In Patients Receiving Lomab-B Presented At 2021 SNMMI Virtual Conference
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium") today highlighted safety data from its ongoing pivotal Phase 3 SIERRA trial of Iomab-B in patients with relapsed or refractory Acute Myeloid
Actinium Pharmaceuticals Details SIERRA at Benzinga Global Small Cap Business Conference
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company that develops antibody radiation-conjugates (ARC), took part in the Benzinga Global Small Cap Business Conference on May 13, 2021.
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing antibody radiation-conjugates (ARCs) to combine the targeting ability of antibodies with the cell-killing ability of radiation.
Shares Of Pharmacy/Healthcare Stocks Quiet As Traders Circulate Statement From FTC Commissioner Dated Friday That Criticizes Pharmacy Benefits Manager Industry, Is Calling For FTC, Congress To Take Steps To Address Issues In Industry
https://www.ftc.gov/system/files/documents/public_statements/1590528/statement_of_commissioner_rohit_chopra_regarding_the_commissions_report_on_pharmacy_benefit_manager.pdf